🔴 Atea Pharmaceuticals is trading 10.45% down today in pre-market — no clear company-specific catalyst identified

Atea Pharmaceuticals is trading 10.45% down at $4.80, with no clear company-specific catalyst identified for August 31, 2026.

• The latest identified company announcement was August 12, 2026, covering second-quarter results and positive Phase 3 C-BEYOND data.
• U.S. equity futures are modestly lower, but the broader decline does not clearly explain this larger move.
• Volume and activity details were unavailable.